Research Article

Trends in Breast Cancer Incidence Rates by Age and Stage at Diagnosis in Gharbiah, Egypt, over 10 Years (1999–2008)

Table 1

Characteristics of breast cancer cases ( ) by year of diagnosis in Gharbiah, Egypt, 1999–2008.

Year of diagnosis Overall
(%)
valuea
1999
(%)
2000
(%)
2001
(%)
2002
(%)
2003
(%)
2004
(%)
2005
(%)
2006
(%)
2007
(%)
2008
(%)

Age
 0–2918 (2.9)15 (2.5)10 (1.6)22 (3.5)14 (2.0)15 (2.1)21 (2.9)9 (1.2)13 (1.7)22 (2.6)159 (2.3)0.0051
 30–39103 (16.6)107 (18.0)110 (17.5)104 (16.5)115 (16.9)103 (14.4)100 (13.7)101 (13.0)88 (11.2)113 (13.5)1044 (14.9)
 40–49215 (34.7)180 (30.4)214 (34.1)195 (30.9)223 (32.7)216 (30.3)229 (31.5)263 (33.8)235 (29.9)253 (30.2)2223 (31.8)
 50–59164 (26.5)177 (29.9)172 (27.4)178 (28.2)198 (29.0)218 (30.5)209 (28.7)244 (31.4)255 (32.5)271 (32.3)2086 (29.8)
 60–6994 (15.2)76 (12.8)77 (12.3)91 (14.4)101 (14.8)109 (15.3)117 (16.1)110 (14.1)129 (16.4)122 (14.6)1026 (14.7)
 70+26 (4.2)38 (6.4)45 (7.2)41 (6.5)31 (4.6)53 (7.4)52 (7.1)51 (6.6)65 (8.3)57 (6.8)459 (6.6)
 Overall620 (8.9)593 (8.5)628 (9.0)631 (9.0)682 (9.8)714 (10.2)728 (10.4)778 (11.1)785 (11.2)838 (12.1)6997 (100)
ERb
 Positiven/an/a218 (34.7)193 (30.6)214 (31.4)265 (37.1)265 (36.4)391 (50.3)356 (45.4)228 (27.2)2130 (36.9) <0.0001
 Negativen/an/a69 (11.0)92 (14.6)112 (16.4)112 (15.7)127 (17.4)148 (19.0)137 (17.5)133 (15.9)930 (16.1)
 Missingn/an/a341 (54.3)346 (54.8)356 (52.2)337 (47.2)336 (46.2)239 (30.7)292 (37.2)477 (56.9)2724 (47.1)
PRc
 Positiven/an/a126 (20.1)110 (17.4)135 (19.8)157 (22.0)194 (26.6)314 (40.3)272 (34.6)181 (21.6)1489 (25.7)<0.0001
 Negativen/an/a98 (15.6)104 (16.5)111 (16.3)104 (14.6)115 (15.8)125 (16.1)160 (20.4)139 (16.6)956 (16.5)
 Missingn/an/a404 (64.3)417 (66.1)436 (63.9)453 (63.4)419 (57.6)339 (43.6)353 (45.0)518 (61.8)3339 (57.7)
Stage
 Localized92 (14.8)106 (17.9)143 (22.8)138 (21.9)142 (20.8)137 (19.2)160 (22.0)177 (22.8)181 (23.1)179 (21.4)1455 (20.8)<0.0001
 Regional314 (50.6)275 (46.4)313 (49.8)323 (51.2)327 (47.9)360 (50.4)359 (49.3)387 (49.7)365 (46.5)453 (54.1)3476 (49.7)
 Distant87 (14.0)95 (16.0)83 (13.2)71 (11.3)100 (14.7)94 (13.2)77 (10.6)77 (9.9)95 (12.1) 55 (6.6) 834 (11.9)
 Missing127 (20.5)117 (19.7)89 (14.2)99 (15.7)113 (16.6)123 (17.2)132 (18.1)137 (17.6)144 (18.3)151 (18.0)1232 (17.6)
Laterality
 Right267 (43.1)255 (43.0)261 (41.6)269 (42.6)287 (42.1)327 (43.0)307 (42.2)351 (45.1)319 (40.6)405 (48.3)3048 (43.6)<0.0001
 Left284 (45.8)273 (46.0)324 (51.6)332 (52.6)344 (50.4)340 (51.8)370 (50.8)373 (47.9)398 (50.7)399 (47.6)3437 (49.1)
 Bilateral5 (0.8)3 (0.5)6 (1.0)5 (0.8)9 (1.3)5 (1.1)8 (1.1)5 (0.6)2 (0.3)5 (0.6)53 (0.8)
 Missing64 (10.3)62 (10.5)37 (5.9)25 (4.0)42 (6.2)42 (6.0)43 (5.9)49 (6.3)66 (8.4)29 (3.5)459 (6.6)
Basis
 Histology398 (64.2)469 (79.1)468 (74.5)518 (82.1)553 (81.1)571 (80.0)592 (81.3)652 (83.8)626 (79.8)673 (80.3)5520 (78.9)<0.0001
 FNACd168 (27.1)83 (14.0)142 (22.6)99 (15.7)105 (15.4)118 (16.5)113 (15.5)107 (13.8)138 (17.6)150 (17.9)1223 (17.5)
 Others54 (8.7)40 (6.7)18 (2.9)14 (2.2)23 (3.4)24 (3.4)23 (3.2)19 (2.4)21 (2.7)15 (1.8)251 (3.6)
 Missing0 (0.0) 1 (0.2)0 (0.0) 0 (0.0) 1 (0.1)1 (0.1)0 (0.0) 0 (0.0)0 (0.0)0 (0.0)3 (0.0)

value based on chi-square test.
bEstrogen receptor status.
cProgesterone receptor status.
dFine needle aspiration cytology.